This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Progenics Pharmaceuticals Inc (PGNX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 74.10M 119.30M 65.86M 58.84M
Receivables 3.54M 109.00K 2.88M 6.94M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 5.64M 2.52M 1.94M 1.69M
Total Current Assets 83.28M 121.93M 70.68M 67.47M
Property, Plant & Equipment, Gross 12.68M 12.37M 14.53M 15.67M
Accumulated Depreciation & Depletion 10.27M 9.82M 12.12M 12.27M
Property, Plant & Equipment, Net 2.41M 2.55M 2.41M 3.40M
Intangibles 30.79M 28.70M 31.38M 0.00
Other Non-Current Assets 1.69M 157.00K 2.37M 3.39M
Total Non-Current Assets 47.97M 39.11M 43.86M 8.84M
Liabilities & Shareholder Equity
Total Assets 131.25M 161.04M 114.54M 76.31M
Accounts Payable 452.00K 1.04M 793.00K 229.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 867.00K 0.00 431.00K 115.00K
Total Current Liabilities 9.73M 6.68M 6.63M 8.66M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 11.20M 11.33M 12.32M 0.00
Other Non-Current Liabilities 19.66M 18.11M 16.61M 1.08M
Minority Interest -7.00K 0.00 0.00 0.00
Total Non-Current Liabilities 31.07M 29.44M 28.93M 1.08M
Total Liabilities 40.80M 36.13M 35.56M 9.74M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 90.46M 124.91M 78.98M 66.57M
Common Par 91.00K 91.00K 79.00K 61.00K
Additional Paid In Capital 594.51M 589.83M 548.51M 493.61M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -501.38M -462.27M -466.68M -424.11M
Treasury Stock -2.74M -2.74M -2.74M -2.74M
Other Equity Adjustments -26.00K 0.00 -192.00K -260.00K
Total Capitalization 90.46M 124.91M 78.98M 66.57M
Total Equity 90.46M 124.91M 78.98M 66.57M
Total Liabilities & Stock Equity 131.25M 161.04M 114.54M 76.31M
Total Common Shares Outstanding 69.95M 69.63M 60.83M 46.57M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 200.00K 200.00K 200.00K 200.00K
Basic Weighted Shares Outstanding 69.72M 68.19M 55.80M 34.75M
Diluted Weighted Shares Outstanding 69.72M 68.24M 55.80M 34.75M
Number of Employees 66 57 69 76
Number of Part-Time Employees 0 0 0 0
PGNX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PGNX Progenics Pharmaceuticals Inc

Chart of PGNX

Analysts Ratings for PGNX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PGNX ANALYST REPORT

PGNX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs